The University of Chicago Header Logo

Connection

Sarah K. Keedy to Psychotic Disorders

Back to Details
This is a "connection" page, showing publications Sarah K. Keedy has written about Psychotic Disorders.
Sarah K. Keedy
Connection Strength
7.376
Psychotic Disorders
  1. Real-time facial emotion recognition deficits across the psychosis spectrum: A B-SNIP Study. Schizophr Res. 2022 05; 243:489-499.
    View in: PubMed
    Score: 0.727
  2. Resting state auditory-language cortex connectivity is associated with hallucinations in clinical and biological subtypes of psychotic disorders. Neuroimage Clin. 2020; 27:102358.
    View in: PubMed
    Score: 0.661
  3. Distinguishing patterns of impairment on inhibitory control and general cognitive ability among bipolar with and without psychosis, schizophrenia, and schizoaffective disorder. Schizophr Res. 2020 09; 223:148-157.
    View in: PubMed
    Score: 0.660
  4. Disease and drug effects on internally-generated and externally-elicited responses in first episode schizophrenia and psychotic bipolar disorder. Schizophr Res. 2014 Oct; 159(1):101-6.
    View in: PubMed
    Score: 0.437
  5. Clinical characterization and differentiation of B-SNIP psychosis Biotypes: Algorithmic Diagnostics for Efficient Prescription of Treatments (ADEPT)-1. Schizophr Res. 2023 10; 260:143-151.
    View in: PubMed
    Score: 0.205
  6. Peripheral inflammatory subgroup differences in anterior Default Mode network and multiplex functional network topology are associated with cognition in psychosis. Brain Behav Immun. 2023 11; 114:3-15.
    View in: PubMed
    Score: 0.203
  7. Characterization of childhood trauma, hippocampal mediation and Cannabis use in a large dataset of psychosis and non-psychosis individuals. Schizophr Res. 2023 05; 255:102-109.
    View in: PubMed
    Score: 0.199
  8. Peripheral inflammation is associated with impairments of inhibitory behavioral control and visual sensorimotor function in psychotic disorders. Schizophr Res. 2023 05; 255:69-78.
    View in: PubMed
    Score: 0.199
  9. Using psychosis biotypes and the Framingham model for parsing psychosis biology. Schizophr Res. 2022 04; 242:132-134.
    View in: PubMed
    Score: 0.184
  10. Psychosis Biotypes: Replication and Validation from the B-SNIP Consortium. Schizophr Bull. 2022 01 21; 48(1):56-68.
    View in: PubMed
    Score: 0.183
  11. Impact of polygenic risk for coronary artery disease and cardiovascular medication burden on cognitive impairment in psychotic disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2022 03 08; 113:110464.
    View in: PubMed
    Score: 0.180
  12. Neural Processing of Repeated Emotional Scenes in Schizophrenia, Schizoaffective Disorder, and Bipolar Disorder. Schizophr Bull. 2021 08 21; 47(5):1473-1481.
    View in: PubMed
    Score: 0.178
  13. Auditory Oddball Responses Across the Schizophrenia-Bipolar Spectrum and Their Relationship to Cognitive and Clinical Features. Am J Psychiatry. 2021 10 01; 178(10):952-964.
    View in: PubMed
    Score: 0.178
  14. Deficits in generalized cognitive ability, visual sensorimotor function, and inhibitory control represent discrete domains of neurobehavioral deficit in psychotic disorders. Schizophr Res. 2021 10; 236:54-60.
    View in: PubMed
    Score: 0.178
  15. An opportunity for primary prevention research in psychotic disorders. Schizophr Res. 2022 05; 243:433-439.
    View in: PubMed
    Score: 0.177
  16. Genome-wide association study accounting for anticholinergic burden to examine cognitive dysfunction in psychotic disorders. Neuropsychopharmacology. 2021 09; 46(10):1802-1810.
    View in: PubMed
    Score: 0.176
  17. Multivariate relationships between peripheral inflammatory marker subtypes and cognitive and brain structural measures in psychosis. Mol Psychiatry. 2021 07; 26(7):3430-3443.
    View in: PubMed
    Score: 0.168
  18. Biotyping in psychosis: using multiple computational approaches with one data set. Neuropsychopharmacology. 2021 01; 46(1):143-155.
    View in: PubMed
    Score: 0.167
  19. Catechol-O-methyltransferase genotype differentially contributes to the flexibility and stability of cognitive sets in patients with psychotic disorders and their first-degree relatives. Schizophr Res. 2020 09; 223:236-241.
    View in: PubMed
    Score: 0.166
  20. Testing Psychosis Phenotypes From Bipolar-Schizophrenia Network for Intermediate Phenotypes for Clinical Application: Biotype Characteristics and Targets. Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 08; 5(8):808-818.
    View in: PubMed
    Score: 0.163
  21. NMDA receptor antibody seropositivity in psychosis: A pilot study from the Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP). Schizophr Res. 2020 04; 218:318-320.
    View in: PubMed
    Score: 0.159
  22. Brain gray matter network organization in psychotic disorders. Neuropsychopharmacology. 2020 03; 45(4):666-674.
    View in: PubMed
    Score: 0.158
  23. Relationship of prolonged acoustic startle latency to diagnosis and biotype in the bipolar-schizophrenia network on intermediate phenotypes (B-SNIP) cohort. Schizophr Res. 2020 02; 216:357-366.
    View in: PubMed
    Score: 0.158
  24. NRXN1 is associated with enlargement of the temporal horns of the lateral ventricles in psychosis. Transl Psychiatry. 2019 09 17; 9(1):230.
    View in: PubMed
    Score: 0.156
  25. Auditory steady-state EEG response across the schizo-bipolar spectrum. Schizophr Res. 2019 07; 209:218-226.
    View in: PubMed
    Score: 0.152
  26. Alterations in intrinsic fronto-thalamo-parietal connectivity are associated with cognitive control deficits in psychotic disorders. Hum Brain Mapp. 2019 01; 40(1):163-174.
    View in: PubMed
    Score: 0.145
  27. Psychosis subgroups differ in intrinsic neural activity but not task-specific processing. Schizophr Res. 2018 05; 195:222-230.
    View in: PubMed
    Score: 0.135
  28. Intrinsic neural activity differences among psychotic illnesses. Psychophysiology. 2017 Aug; 54(8):1223-1238.
    View in: PubMed
    Score: 0.132
  29. Cognitive burden of anticholinergic medications in psychotic disorders. Schizophr Res. 2017 12; 190:129-135.
    View in: PubMed
    Score: 0.131
  30. Symptom dimensions of the psychotic symptom rating scales in psychosis: a multisite study. Schizophr Bull. 2014 Jul; 40 Suppl 4:S265-74.
    View in: PubMed
    Score: 0.109
  31. Reduced levels of vasopressin and reduced behavioral modulation of oxytocin in psychotic disorders. Schizophr Bull. 2014 Nov; 40(6):1374-84.
    View in: PubMed
    Score: 0.106
  32. Neurophysiological evidence of corollary discharge function during vocalization in psychotic patients and their nonpsychotic first-degree relatives. Schizophr Bull. 2013 Nov; 39(6):1272-80.
    View in: PubMed
    Score: 0.097
  33. Phenomenology of first-episode psychosis in schizophrenia, bipolar disorder, and unipolar depression: a comparative analysis. Clin Schizophr Relat Psychoses. 2012 Oct; 6(3):145-51.
    View in: PubMed
    Score: 0.096
  34. White matter microstructure in untreated first episode bipolar disorder with psychosis: comparison with schizophrenia. Bipolar Disord. 2011 Nov-Dec; 13(7-8):604-13.
    View in: PubMed
    Score: 0.090
  35. Altered transfer of visual motion information to parietal association cortex in untreated first-episode psychosis: implications for pursuit eye tracking. Psychiatry Res. 2011 Oct 31; 194(1):30-8.
    View in: PubMed
    Score: 0.089
  36. Pharmacological treatment effects on eye movement control. Brain Cogn. 2008 Dec; 68(3):415-35.
    View in: PubMed
    Score: 0.074
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.